No recent analyst price targets found for NEGXF.
Latest News for NEGXF
NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth
TORONTO, ON / ACCESS Newswire / May 21, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2026, with net income of $1,228,288 and EBITDA of $1,444,036, representing increases of $701,078 and $615,635, respectively, compared to the same period in 2025.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for NEGXF.
Senate Trading
No Senate trades found for NEGXF.
U.S. House Trading
No House trades found for NEGXF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.